Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A Randomized, Double-Blind, Placebo-Controlled Trial of Omalizumab Combined with Oral Immunotherapy (OIT) in the Treatment of Cow's Milk Allergy (CMA): Safety of Dosing Kim, J. S., Wood, R. A., Lindblad, R., Noone, S. A., Paterakis, M. N., Henning, A., Nadeau, K. C., Spann, K., Sampson, H. A. MOSBY-ELSEVIER. 2014: AB403
View details for DOI 10.1016/j.jaci.2013.12.1067
View details for Web of Science ID 000330241302019